Company intelligence / Profile preview

Daicel Chiral Technologies

Ownership: Private
Development stage: Commercial

Overview

Daicel Chiral Technologies is the global leader in enantioselective chromatography solutions. It supplies the largest portfolio of chiral stationary phases and analytical/preparative columns for separating racemic mixtures into single enantiomers. Its products are essential in drug discovery/development pipelines across pharma and biotech industries.

Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Daicel Chiral Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daicel Chiral Technologies.

Explore the full profile